DMCBH and UBC ARC Invite You to the UBC Digital Research Infrastructure Showcase on Fri Feb 19 @ 12:30pm



UBC Advanced Research Computing (ARC), in partnership with Djavad Mowafaghian Centre for Brain Health (DMCBH), invite you to their showcase of the UBC ARC digital research infrastructure Sockeye and Chinook on Friday February 19, 2021, at 12:30pm.

This talk will provide an introduction to UBC ARC services, including the high-performance computing system and object storage platform, as well as firsthand testimonies from DMCBH researchers Jennifer Ferris, PhD Candidate, and Jonathan Doucette, PhD Candidate, on how Sockeye has helped expedite their research.  The presentation will conclude with a demonstration on the application process, use of MATLAB on Sockeye, and introduction to ARC staff available for consults and assistance.


All Attendees Welcome

When: Friday February 19, 2021
Time: 12:30 pm PST
Connect on Zoom:
Meeting ID: 168 788 388
Passcode: 778293



UBC ARC Sockeye is a high-performance computing platform available to UBC researchers across all disciplines. With nearly 16,000 CPU cores and 200 GPUs, Sockeye is deigned to significantly increase UBC’s computing capacity and supplement resources available on national platforms.

UBC ARC Chinook is a new object storage platform, available to all UBC researchers. With an initial 5 PB of storage, it has been designed to increase storage capacity to meet the immediate needs of UBC researchers.


Speaker(s) Bio:

Jonathan Doucette: Jon is a PhD student in the Department of Physics & Astronomy studying MRI physics under the supervision of Dr. Alexander Rauscher. Jon’s work focuses on investigating brain tissue microstructure through MRI signal simulations, as well as accelerating MRI post-processing algorithms using Bayesian deep learning.

Jennifer Ferris: Jenn is a PhD Candidate in Rehabilitation Sciences, working under the supervision of Dr. Lara Boyd. Her research employs multimodal neuroimaging to study brain damage related to stroke and cerebral small vessel disease.

Questions email/contact: